Skip to main content
Veterinary Medicines

Animec Super 10 mg/ml / 100 mg/ml Solution for Injection for Cattle

Authorised
  • Clorsulon
  • Ivermectin

Product identification

Medicine name:
Animec Super 10 mg/ml / 100 mg/ml Solução injetável para Bovinos
Animec Super 10 mg/ml / 100 mg/ml Solution for Injection for Cattle
Active substance:
  • Clorsulon
  • Ivermectin
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clorsulon
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Ivermectin
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        66
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA51
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • 500 ml High density polyethylene bottle
  • 250 ml High density polyethylene bottle
  • 50 ml High density polyethylene bottle

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chanelle Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 11990/4054
Date of authorisation status change:
Reference member state:
  • Portugal
Procedure number:
  • PT/V/0133/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • Estonia
  • France
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Romania
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."